Public case informationLast updated
Sandoz Generic Drug Antitrust Class Action Settlement
Sandoz · Generic drugs · Settlement Reached
About this case
Sandoz agreed to pay $28.5 million to resolve damage claims in an indirect reseller class action alleging that the company participated in anticompetitive conduct involving generic drug pricing. The settlement agreement was announced, but its final approval status is not specified.
Case overview
- Defendant company
- Sandoz
- Product or service
- Generic drugs
- Case status
- Settlement Reached
- Lawsuit type
- Antitrust
- Reported harm
- Competition Pricing
Participation information
No active participation options are currently listed.
Sources
- Sandoz Generic Drug Antitrust Class Action Settlement
New Haven Register ·